Blood Cancer and Disease Treatment at King's College Hospital in London, UK
200+ bone marrow transplants yearly, CAR T cell therapy and sickle cell disease treatment treating leukaemia, lymphoma, myeloma, sickle cell disease.
Why Choose KCH for Blood Cancer Treatment in London, UK
Trusted by International Patients
- First UK hospital for CAR T lymphoma therapy, 2019.
- Largest UK sickle cell trial portfolio and treatment centre.
- First GTAC-approved immune gene therapy programme for leukaemia in UK.
- Arabic and Greek interpretation available on-site at no charge.
- Embassy sponsorship accepted from Kuwait, Saudi Arabia, UAE, Qatar.
- Paediatric blood cancer service, jointly managed with children's department.
Advanced Technology at King's College Hospital
- CAR T Cell Manufacturing Suite
- Flow Cytometry (Bone Marrow Analysis)
- Next-Generation Sequencing (NGS)
- PET-CT Staging for Blood Cancers
- Bone Marrow Aspiration and Trephine Biopsy
- Apheresis (Stem Cell Collection)
- High-Resolution HLA Typing
- CRISPR Base-Editing Gene Therapy
Blood Cancer and Blood Disease Treatment at KCH for International Patients
Every treatment is discussed by a MDT team, tailored to your diagnosis, prior treatment history, specific disease subtype.
Bone marrow transplant
Stem cell transplant replacing diseased marrow with healthy donor cells, at the UK's largest BMT programme.
Inquire
CAR T Cell Therapy
Engineers your own immune cells to find and destroy blood cancer cells at the UK's 1st and largest CAR T programme.
Inquire
Leukaemia Treatment
Medical and transplant treatment for acute and chronic leukaemia, at the only European centre with expertise across all main subtypes.
Inquire
Lymphoma Treatment
Chemotherapy, immunotherapy, radiotherapy, and CAR T therapy for Hodgkin and non-Hodgkin lymphoma.
Inquire
Sickle Cell Disease Treatment
Medical management and curative bone marrow transplant at the UK's largest sickle cell centre.
Inquire
MDS Treatment
Specialist treatment for myelodysplastic syndrome including matched and unrelated donor transplants at a designated Centre of Excellence.
Inquire
Paediatric Blood Cancer Treatment
Blood cancer and disorder treatment for children and young adults, jointly managed by haematology and paediatric teams.
Inquire
Care Journey for International Patients
Your cancer treatment journey made simple and stress-free in 5 easy steps
-
1
Online inquiry & medical files upload Share your medical reports for review. It takes less than a minute.
-
2
Doctor review & treatment plan Within 24hrs you will receive treatment options & a preliminary plan before travel.
-
3
Travel coordination We arrange your visa, flights, and accommodation.
-
4
Treatment phase Full care under a dedicated case manager.
-
5
Start your treatment Begin treatment with full support from our care team.
Frequently Asked Questions
Have a question? Our support team is here to guide you through each step of your treatment journey with personal care and attention.Can international patients access CAR T cell therapy at King's?
Yes. CAR T is available to international private patients at King's, which delivered the UK's 1st CAR T infusion for lymphoma in January 2019 and has the largest case volume nationally.
- Yescarta: relapsed or refractory DLBCL, primary mediastinal B-cell lymphoma, transformed follicular lymphoma
- Tecartus: relapsed or refractory mantle cell lymphoma
- Kymriah: DLBCL, transformed follicular lymphoma, and patients aged 18 to 25 with relapsed or refractory ALL
King's also runs clinical trial CAR programmes in myeloma and follicular lymphoma. Submit your diagnosis and treatment history via WhatsApp at +447481338875 or [email protected].
How do I contact the international patient team for blood cancer treatment at King's?
Reports review, appointments, and treatment planning for blood cancer are coordinated through My 1Health's international patient team.
- WhatsApp: +447481338875
- Telephone: +447481338875
- Email: [email protected]
Available 24/7. The team arranges video consultations with haematology specialists, reviews bone marrow biopsy results, blood tests, and treatment history, and provides a written cost estimate, itinerary, visa documentation, airport transfers, and accommodation booking.
How long do international patients need to stay in the UK for bone marrow transplant?
- Allogeneic transplant (donor cells): 4 to 6 weeks in hospital; 8 to 12 weeks total in the UK before flying
- Autologous transplant (own cells): shorter hospital stay, lower complication risk, quicker recovery
- CAR T therapy: 2 to 4 weeks in hospital; outpatient follow-up for several additional weeks
My 1Health helps book accommodation near King's at no extra coordination cost. A written itinerary covering every stage is provided before you travel.
How much does blood cancer treatment cost at King's, and does King's accept international insurance?
Costs vary by diagnosis, treatment, hospital stay, and whether the procedure is autologous or allogeneic. King's offers 400+ fixed package prices for standard procedures. BMT and CAR T therapy are priced individually based on the full clinical assessment.
- International insurance: Allianz Worldwide Care, Bupa International, Cigna International, and others
- Embassy sponsorship: Kuwait Health Office, Dubai Health Authority, Saudi Royal Embassy, Qatar Embassy, UAE Embassy, Bahrain Embassy, Jordanian Embassy
- Self-funded: bank transfer, credit card, or cash
Request a written cost estimate via WhatsApp at +447481338875 or [email protected] before any commitment.
Is bone marrow transplant available without a fully matched donor?
Yes. King's performs haploidentical (half-matched) transplants using a parent, child, or sibling as the donor.
Cord blood transplants and unrelated donor matches through international bone marrow registries are also available. King's pioneered reduced-intensity non-related BMT for patients over 50 with myeloid leukaemia, now used globally. Submit your reports to confirm donor options specific to your case before you travel.
What blood cancers and disorders does King's treat for international patients?
King's treats a broad range of blood cancers and disorders in adults and children.
- Leukaemias: AML, ALL, CML, CLL
- Lymphomas: Hodgkin, non-Hodgkin (DLBCL, follicular, mantle cell, transformed)
- Multiple myeloma, MDS, myelofibrosis
- Sickle cell disease, thalassaemia, aplastic anaemia, PNH, thrombophilia, platelet disorders
Submit your reports for review if your diagnosis is not listed.
